1. Home
  2. RFL vs MKZR Comparison

RFL vs MKZR Comparison

Compare RFL & MKZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RFL
  • MKZR
  • Stock Information
  • Founded
  • RFL 2017
  • MKZR 2012
  • Country
  • RFL United States
  • MKZR United States
  • Employees
  • RFL N/A
  • MKZR N/A
  • Industry
  • RFL Real Estate
  • MKZR
  • Sector
  • RFL Finance
  • MKZR
  • Exchange
  • RFL Nasdaq
  • MKZR Nasdaq
  • Market Cap
  • RFL 65.4M
  • MKZR 56.6M
  • IPO Year
  • RFL N/A
  • MKZR N/A
  • Fundamental
  • Price
  • RFL $2.01
  • MKZR $2.41
  • Analyst Decision
  • RFL
  • MKZR
  • Analyst Count
  • RFL 0
  • MKZR 0
  • Target Price
  • RFL N/A
  • MKZR N/A
  • AVG Volume (30 Days)
  • RFL 41.9K
  • MKZR 97.8K
  • Earning Date
  • RFL 03-12-2025
  • MKZR 01-01-0001
  • Dividend Yield
  • RFL N/A
  • MKZR 7.26%
  • EPS Growth
  • RFL N/A
  • MKZR N/A
  • EPS
  • RFL N/A
  • MKZR N/A
  • Revenue
  • RFL $697,000.00
  • MKZR $17,563,335.00
  • Revenue This Year
  • RFL N/A
  • MKZR N/A
  • Revenue Next Year
  • RFL N/A
  • MKZR N/A
  • P/E Ratio
  • RFL N/A
  • MKZR N/A
  • Revenue Growth
  • RFL 151.62
  • MKZR N/A
  • 52 Week Low
  • RFL $1.29
  • MKZR $1.05
  • 52 Week High
  • RFL $2.50
  • MKZR $5.50
  • Technical
  • Relative Strength Index (RSI)
  • RFL 58.35
  • MKZR N/A
  • Support Level
  • RFL $1.83
  • MKZR N/A
  • Resistance Level
  • RFL $2.01
  • MKZR N/A
  • Average True Range (ATR)
  • RFL 0.15
  • MKZR 0.00
  • MACD
  • RFL 0.02
  • MKZR 0.00
  • Stochastic Oscillator
  • RFL 94.44
  • MKZR 0.00

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.

About MKZR MacKenzie Realty Capital Inc.

Mackenzie Realty Capital Inc is a company which is a Real estate investment trust (REIT). The company has one reportable segment, income-producing real estate properties which consists of activities related to investing in real estate.

Share on Social Networks: